Global Cell Therapy Competitive Landscape Professional Research Report 2024
Research Summary
Cell therapy, also known as cellular therapy, is a therapeutic approach that utilizes living cells to treat or prevent diseases and disorders. It involves the administration of cells, either autologous (derived from the patient) or allogeneic (donor-derived), with the aim of replacing damaged or dysfunctional cells, stimulating the body's immune response, or delivering therapeutic molecules. Cell therapy encompasses a wide range of techniques and applications, including stem cell therapy, immunotherapy, and regenerative medicine. Stem cell therapy involves the use of stem cells, which have the potential to differentiate into various cell types, to repair or regenerate damaged tissues or organs. Immunotherapy utilizes immune cells or engineered cells to enhance the immune system's ability to recognize and eliminate cancer cells or other pathogens. Regenerative medicine focuses on using cells to stimulate tissue repair or promote the regeneration of damaged tissues or organs. Cell therapy holds promise for treating a variety of conditions, including cancer, genetic disorders, autoimmune diseases, neurodegenerative disorders, and cardiovascular diseases, and represents a rapidly evolving field at the forefront of medical research and innovation.
According to DIResearch's in-depth investigation and research, the global Cell Therapy market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.
The major global manufacturers of Cell Therapy include Gilead Sciences, Novartis, Osiris, Vericel Corporation, Vcanbio, Fujifilm Cellular Dynamics, JCR Pharmaceuticals, Beike Biotechnology, Golden Meditech, Guanhao Biotech etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Cell Therapy. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Cell Therapy market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Cell Therapy market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Cell Therapy industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Cell Therapy Include:
Gilead Sciences
Novartis
Osiris
Vericel Corporation
Vcanbio
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech
Guanhao Biotech
Cell Therapy Product Segment Include:
Stem Cell
Non-Stem Cell
Cell Therapy Product Application Include:
Hospital
Clinic
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Cell Therapy Industry PESTEL Analysis
Chapter 3: Global Cell Therapy Industry Porter’s Five Forces Analysis
Chapter 4: Global Cell Therapy Major Regional Market Size and Forecast Analysis
Chapter 5: Global Cell Therapy Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Cell Therapy Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Cell Therapy Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources